Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome.

@article{Chin1996EffectsON,
  title={Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome.},
  author={K. Chin and M. Ohi and H. Kita and T. Noguchi and N. Otsuka and T. Tsuboi and M. Mishima and K. Kuno},
  journal={American journal of respiratory and critical care medicine},
  year={1996},
  volume={153 6 Pt 1},
  pages={
          1972-6
        }
}
  • K. Chin, M. Ohi, +5 authors K. Kuno
  • Published 1996
  • Medicine
  • American journal of respiratory and critical care medicine
  • In patients with obstructive sleep apnea syndrome (OSAS), the blood coagulation system may contribute to an increased risk of cardiovascular events, which occur most frequently in the morning. Nasal continuous positive airway pressure (NCPAP) treatment can improve the mortality of patients with OSAS. We measured the plasma fibrinogen concentration, which is an independent risk factor for cardiovascular events, in the afternoon (3:30 P.M.) and the next morning upon awakening (8:30 A.M.) in 11… CONTINUE READING
    237 Citations
    Fibrinogen levels and obstructive sleep apnea in ischemic stroke.
    • 219
    Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure.
    • 43
    Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea.
    • 39
    Clinical Utility of Biochemical Markers of Obstructive Sleep Apnea
    • 1